Evaluating vaccines for HIV prevention using nonhuman primates
Official title: Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support
Funded at Bioqual, INC. · NIH-10138755 · Data updated 2026-11-12
This study is working on creating better vaccines and prevention methods for HIV by testing them in nonhuman primates, which helps researchers learn how to protect people from the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Bioqual, INC. NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project start | April 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2020 |
| Award (this year) | $393,447 |
| NIH project number | 75N93020D00006-0-759302000001-1 |
| Project ID | NIH-10138755 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals at high risk for HIV who may eventually receive effective vaccines developed through these studies.
✕Less likely to help
Patients who are already living with HIV or those who do not have access to future vaccine options may not benefit directly from this research.
What this research studies
This research focuses on the development and evaluation of effective HIV vaccines and prevention strategies through the use of nonhuman primates (NHPs). The Simian Vaccine Evaluation Units (SVEUs) provide essential resources for preclinical studies, allowing researchers to assess candidate AIDS vaccines and their ability to generate immune responses. The program supports various stages of vaccine research, including testing vaccine efficacy and identifying factors that enhance immune protection against HIV. By utilizing NHP models, the research aims to improve our understanding of how to prevent or control HIV infection in humans.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that significantly reduce the risk of HIV infection in humans.
How similar studies have gone: Previous research using nonhuman primates for HIV vaccine evaluation has shown promise, indicating that this approach is both tested and has the potential for significant breakthroughs.
Where this research is happening
-
Bioqual, INC.
Rockville, United States Active
Researchers
- Principal investigator: Lewis, Mark — Bioqual, INC.
- Study coordinator: Lewis, Mark
Related research
Other NIH-funded projects on the same topics.
-
Developing models to understand infectious diseases.
This study is working on building models that mimic infectious diseases to help researchers find better ways to treat them, which could lead to new and improved options for patients like you.
-
Developing models to understand infectious diseases.
This study is working on creating models that mimic infectious diseases to help researchers find better treatments, which could eventually lead to improved therapies for patients dealing with these illnesses.
-
Evaluating vaccines for HIV using nonhuman primates
This study is looking at how well different HIV vaccines and prevention methods work using nonhuman primates, with the goal of finding effective ways to stop or control HIV infection.
-
Evaluating vaccines to prevent HIV using nonhuman primates
This study is testing new HIV vaccines using monkeys to see how well they work and how they help the immune system, with the goal of finding effective ways to prevent or control HIV for everyone.
-
Using a virus to deliver antibodies that protect against SIV infection
This study is looking at a new way to help protect against the Simian Immunodeficiency Virus (SIV) by using special antibodies delivered through a harmless virus, and it's being tested in nonhuman primates to find better strategies for future HIV vaccines and treatments.
-
Evaluating vaccines for HIV using nonhuman primates
This study is looking at how well potential vaccines and prevention methods for HIV/AIDS work using nonhuman primates, helping researchers find effective ways to protect people from the virus.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.